The bear case on Eli Lilly has played out, says only firm to have called it a sell
The bear case for Eli Lilly has now played out following the reaction to the drugmaker’s oral obesity drug trial, an analyst said Wednesday in upgrading the stock.
Business & Finance
Stay informed with expert takes on business strategy, investing, entrepreneurship, and global markets. CurioAtlas brings you articles that guide smarter decisions in finance and business growth.
Lululemon faces lack of fashion cohesion and investor ‘frustration’ ahead of earnings. Here’s why.
As the athleisure company prepares to report quarterly results next week, some Wall Street analysts say they still don’t have a clear sense of why its North American business has stumbled.
Israeli tanks close in on Gaza City, Trump to chair meeting
Post Content
Amylyx Pharmaceuticals discontinues ORION program for AMX0035 in PSP
Post Content
Newmont planning to cut jobs in cost-cut drive, Bloomberg News reports
Post Content
Form 8K Foot Locker For: 27 August
Post Content
Analysis-Investors worry Trump’s Intel deal kicks off era of US industrial policy
Post Content
Form 8K Kohl’s Corp For: 27 August
Post Content
Form 8K Inspired Entertainment Inc For: 27 August
Post Content
The central bank with the third-largest reserves is swapping dollars for euros
There has been lots of talk about central banks diversifying away from dollars but the SNB is among the first to confirm it.